Image

Trust in AI and Digitalization in Healthcare Across Generational Groups: A Comparative Study of Barriers and Facilitators Toward Equitable Adoption.

Trust in AI and Digitalization in Healthcare Across Generational Groups: A Comparative Study of Barriers and Facilitators Toward Equitable Adoption.

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study aims to investigate differences in perception of barriers and facilitators of digitalization and Artificial Intelligence (AI) usage in healthcare across different generational groups (youth, working-age adults, and seniors). The results will help create practical recommendations for public health projects and consultants to support fair and inclusive use of new digital tools in healthcare. A cross-sectional online survey will be conducted among students at HAW, patients and employees in the rehabilitation center in Oldenburg, and seniors participating in the "Digital im Alter"(DIA) project.

Description

This study will use an online questionnaire to collect data from respondents about their attitudes toward digital technologies and artificial intelligence in healthcare, as well as their opinions about barriers and facilitators for the equal adoption of modern technologies. The survey will be conducted in November to December 2025.

The survey will use validated scales, including the eHealth Literacy Scale (eHEALS) and the Human-Computer Trust Scale (HCTS), combined with additional items assessing perceived barriers and facilitators. Open-ended questions will allow participants to express their views on barriers and facilitators in their own words and from their perspective.

Eligibility

Inclusion Criteria:

  • Age 18 or older
  • Belonging to one of the defined participant groups
  • Consent to participate in the online survey
  • Ability to participate in the survey (e.g., sufficient German or English language skills)

Exclusion Criteria:

  • Individuals under 18
  • Inability to give informed consent
  • Illiteracy

Study details
    Digital Health
    Artificial Intelligence (AI)

NCT07265427

Jacobs University Bremen gGmbH

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.